Quantcast

Latest Inhaler Stories

2011-05-18 09:15:00

REDWOOD CITY, Calif., May 18, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. presented detailed efficacy and safety results today from the Company's phase 2b study of PT003 (GFF MDI) in patients with moderate-to-very severe COPD during a late-breaker poster session at the annual meeting of the American Thoracic Society (ATS). PT003 is a proprietary fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA), and formoterol fumarate (FF), an established,...

16f6f3708d76ec7c8a74e51fe5ef48bf
2011-05-13 07:57:28

Nicotine-free plastic inhalers may increase a smoker's chance of quitting, according to new research published online in the European Respiratory Journal. This study is the first to assess the effectiveness of using a nicotine-free inhaler to help stop smoking. The research, which was carried out by scientists at the Università di Catania in Italy, analyzed 120 people who were enrolled in a program to help them quit smoking. The participants were split into two groups, with...

2011-05-06 07:32:05

(Ivanhoe Newswire) -- A new study shows a rarely-prescribed drug is easier to use and may be just as effective as treatment with inhalers. Asthma affects about 300 million people worldwide. It is a chronic condition characterized by inflammation of the airways that leads to wheezing, coughing, chest tightness and shortness of breath. Researchers followed 650 patients with chronic asthma for two years. They found leukotriene receptor antagonists (LTRAs) were just as successful at managing the...

2011-05-05 13:01:28

A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA). Publishing tomorrow in the New England Journal of Medicine, the researchers followed 650 patients with chronic asthma for two years. They found that tablets called leukotriene receptor antagonists (LTRAs) managed the disease equally successfully as steroid inhalers and other 'preventer' inhalers when used in...

5aaa50e05b1fe6dcd3a041cdcfcda261
2011-05-05 10:25:00

Asthma sufferers are more often prescribed inhalers than pills to treat their symptoms. However, a British study published in the New England Journal of Medicine (NEJM) suggests that pills marketed under brand names such as Singulair and Accolate work just as well and are easier for patients to manage, reports AFP. Led by Professor David Price of the University of Aberdeen and the University of East Anglia, the study followed 650 chronic asthma patients for two years. Two sub-studies were...

2011-05-05 08:00:00

REDWOOD CITY, Calif., May 5, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. made three presentations at the Respiratory Drug Delivery Europe (RDD Europe 2011) meeting in Berlin this week elucidating the tunability, versatility and universality of the Company's porous particle-based metered dose inhaler (MDI) development approach. The data provides details of Pearl's products and novel cosuspension platform, which facilitates forming stable MDI suspensions containing respiratory drugs as...

2011-05-04 16:00:00

NORWICH, England, May 4, 2011 /PRNewswire/ -- A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA). Publishing tomorrow in the New England Journal of Medicine, the researchers followed 650 patients with chronic asthma for two years. They found that tablets called leukotriene receptor antagonists (LTRAs) managed the disease equally successfully as steroid...

2011-04-29 08:00:00

REDWOOD CITY, Calif., April 29, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. announced today that complete results from the Company's Phase 2b study of PT003 in patients with moderate-to-very severe COPD will be presented during a late-breaker poster session at the upcoming annual meeting of the American Thoracic Society (ATS). PT003 (GFF-MDI) is a proprietary, fixed-dose combination of glycopyrrolate, a long-acting muscarinic antagonist (LAMA), and formoterol, an established, long-acting...

2011-04-19 06:35:00

BOSTON, April 19, 2011 /PRNewswire/ -- InhalerWear announces a new neoprene cover for inhalers that will help make carrying around an inhaler trendy and cool to children and teenagers. The new inhaler cover is affordable, stylish and can simply be clipped to a backpack, sports bag or keychain like an accessory. (Logo: http://photos.prnewswire.com/prnh/20110419/NE84070LOGO ) With nearly 10% of all children suffering from asthma, making sure that children and teens with asthma have...

2011-04-15 00:00:03

Nexus6 and Clement Clarke International announce a collaboration aimed at improving the use of inhaled medications. (PRWEB) April 14, 2011 Nexus6 and Clement Clarke International (CCI) today announced a collaboration aimed at improving the use of inhaled medications. The aim of inhaled medication in asthma and COPD is to enable the patient to maintain control of these conditions, but all too frequently control is not achieved despite widespread availability of effective medications. Some...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related